CBC, short for cannabichromene, is a non-psychoactive cannabinoid found naturally in hemp plants. It won’t get you high, and it’s far less abundant than CBD or THC, but it’s gaining attention for its potential anti-inflammatory, mood-supporting, and skin-related properties. First isolated in 1966, CBC was actually confused with CBD for years because the two compounds have similar chemical structures and behave similarly in lab testing.
How CBC Differs From CBD and THC
Hemp produces over a hundred cannabinoids, but most of the plant’s energy goes into making THC and CBD in specialized structures called stalked trichomes on the flowers. CBC takes a different path. It’s primarily produced and stored in a different type of trichome found on the surface of young leaves, which is one reason it shows up in much smaller concentrations in finished hemp products.
Like CBD, CBC does not produce intoxication. It doesn’t bind strongly to the CB1 receptors in your brain that THC activates to create a high. Instead, CBC selectively activates CB2 receptors, which are concentrated in the immune system and play a role in regulating inflammation. This selective activity is a key distinction: CBC can influence immune responses without altering your mental state.
How CBC Works in the Body
CBC interacts with the body through several pathways beyond the classic cannabinoid receptors. It activates a family of ion channels called TRP channels, particularly TRPA1 and, to a lesser extent, TRPV1. These channels act as sensors throughout your body, detecting pain, temperature, and inflammation. By activating them, CBC can influence how your body processes inflammatory signals and even affect how your own natural endocannabinoids (like anandamide) are taken back up by cells, potentially prolonging their effects.
This creates what researchers describe as a synergistic relationship between CBC as an external plant compound and the endocannabinoids your body already produces. The combined activation of CB2 receptors and TRP channels gives CBC a multi-pronged way of modulating inflammation, which is unusual among individual cannabinoids.
Anti-Inflammatory Effects
CBC’s strongest research backing is in inflammation. Lab studies show it suppresses several key drivers of the inflammatory response: it reduces the production of signaling molecules like IL-6, IL-1β, and TNF-α, which are proteins your immune cells release to amplify inflammation. It also inhibits an enzyme called iNOS that generates nitric oxide, a compound that fuels swelling and tissue damage when overproduced.
These effects happen because CBC blocks two major inflammatory signaling pathways inside cells, the NF-κB and MAPK pathways. Blocking these is significant because they sit upstream of many inflammatory processes, meaning shutting them down has a broad dampening effect rather than targeting just one symptom of inflammation.
Mood and Brain Health
In animal studies, CBC has shown antidepressant-like effects. Mice given CBC at 20 mg/kg showed significantly reduced immobility in a standard behavioral test used to screen for antidepressant activity, a result that was confirmed in a second type of test at higher doses (40 and 80 mg/kg). For context, CBD required a much higher dose of 200 mg/kg to produce similar effects in the same study, suggesting CBC may be more potent in this specific context.
Separately, CBC has shown a positive effect on neural stem cells in the brain. In lab experiments, it increased the viability of these cells during differentiation, essentially helping them survive longer while preventing them from turning into a type of support cell (astroglia) associated with scarring in the brain. This happened through increased ATP levels, the molecule cells use for energy. These findings are preliminary and come from cell cultures rather than human trials, but they point to CBC as a cannabinoid with potential relevance to brain health.
Skin and Acne
CBC suppresses the production of sebum, the oily substance your skin’s sebaceous glands produce. Excess sebum is a core driver of acne, and when researchers tested several non-psychoactive cannabinoids on human sebaceous gland cells, CBC stood out for both reducing baseline oil production and blocking the surge of oil production triggered by arachidonic acid, a fatty acid that mimics acne-like conditions in the lab.
CBC also showed notable anti-inflammatory effects in the same skin cell models, which matters because acne is as much an inflammatory condition as it is an oily-skin problem. Researchers concluded that CBC shows promise as a potential anti-acne agent, alongside THCV, while cannabinoids like CBG actually increased oil production and may be better suited for dry skin.
The Entourage Effect
You’ll often see CBC mentioned alongside the “entourage effect,” the idea that cannabinoids work better together than in isolation. Some research has identified what are called “intra-entourage effects” between CBC and CBD specifically, suggesting the two compounds may enhance each other’s activity when present together in a full-spectrum hemp extract. This is one reason CBC-containing products are often marketed as full-spectrum or broad-spectrum rather than as isolated CBC.
In practical terms, this means you’re more likely to encounter CBC as a supporting ingredient in a hemp extract than as a standalone product, though isolated CBC oils and tinctures do exist.
Safety Profile
CBC has not been studied in large-scale human clinical trials, so its safety data comes primarily from animal research and from what’s known about closely related cannabinoids. No significant adverse effects have been documented for CBC specifically in the existing literature. CBD, which shares structural similarities with CBC, has been studied extensively in humans at doses up to 1,500 mg per day with good tolerability. The most common side effects reported for CBD are tiredness, diarrhea, and changes in appetite or weight.
One important consideration is drug interactions. Cannabinoids are processed by liver enzymes that also break down many common medications. If you take prescription drugs, particularly those metabolized by the CYP3A4 enzyme pathway, cannabinoids could alter how quickly your body processes those medications, either increasing or decreasing their effective dose.
Legal Status of CBC From Hemp
CBC derived from hemp is federally legal in the United States under the 2018 Farm Bill, which removed hemp (defined as cannabis containing less than 0.3% THC by dry weight) from the controlled substances list. The bill preserved the FDA’s authority over how hemp-derived products can be marketed and sold, meaning they must meet the same requirements as any other food, supplement, or cosmetic.
The FDA has specifically ruled that CBD cannot be sold as a dietary supplement or added to food because it’s an active ingredient in an approved drug. That ruling applies to CBD by name, not to CBC. However, the regulatory landscape for individual cannabinoids remains unsettled, and state laws vary. Some states have additional restrictions on cannabinoid products regardless of their federal status.